Abstract A 25 year old British man of previous good health presented with persistent generalised lymphadenopathy and was found to be human immunodeficiency virus (HIV) antibody positive. Three years later after weight loss and loose stools Strongyloides stercoralis was identified in the latter and successfully treated with thiabendazole. Shortly afterwards, a further episode again responded rapidly, but was swiftly followed by a final and fatal illness with severe debility and metabolic imbalance unresponsive to all treatment. Necropsy showed widespread and heavy strongyloidiasis with pulmonary haemorrhage, bronchopneumonia, and meningitis.
The nematode Strongyloides stercoralis, first described by Normand Two months later there was a recurrence, again cleared by thiabendazole (1 5 g twice a day for two days); on discharge the lymphocyte count was 0-42 x 109/l, but the source of the infection remained unknown. After a month he was readmitted with central abdominal pain, bilious vomiting and constipation, weight loss, and for a short time backache and a near generalised papular skin rash.
He was drowsy and dehydrated with persistent generalised lymphadenopathy; the abdomen was diffusely tender, but bowel sounds were active. All other systems were normal.
Laboratory (fig 3) . The Harcourt Thiabendazole is the drug of choice, and initial therapeutic control, as in this patient, is usual. Worms are increasingly becoming resistant, however; side effects are also more common.'0 Comprehensive treatment needs to be started at the earliest stage, but any drug with immunosuppressive effects is contraindicated. The course of this patient illustrates vividly the difficulty of controlling an infection arising in the immunocompromised.
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